|
WASHINGTON (AP) - A federal agency's review of the billion-dollar body parts industry calls for more inspections, but experts in the field say it ignores the problems that led to two recent scares involving human tissue destined for transplant.
An internal task force report Tuesday recommends the Food and Drug Administration require more extensive tracking of non-organ tissue such as tendons, bones and heart valves — from the cadavers where they are retrieved to the patients where they are implanted.
The in-house review also advocated what is essentially the doubling of FDA inspections of companies that remove and handle body parts.
|